Next-Generation Cancer Models from the Human Cancer Models Initiative

Presenter: James Clinton, ATCC | UPM Biomedicals 7th Annual Conference, 2021

James Clinton, Lead Scientist, Research & Development, American Type Culture Collection

James Clinton is a Lead Scientist and group leader with a focus on primary cells and advanced, physiologically relevant culture systems using novel technologies. His Advanced Cell Models team works on the development and commercialization of in vitro models utilizing primary and induced pluripotent stem cells, as well as exploring emerging culture techniques such as 3D organoids and co-culture approaches. Dr. Clinton is principal investigator for ATCC’s collaboration with the National Cancer Institute to support the Human Cancer Models Initiative, an international consortium with a goal of creating 1,000 novel patient derived next-generation cancer models. This effort has so far brought over 170 organoids, neurospheres, conditionally re-programmed cells, and other advanced models from rare and pediatric cancers to the research community. Previously Dr. Clinton worked at University of California, San Diego and the La Jolla Institute for Molecular Medicine. Dr. Clinton attended Washington State University and University of California, San Diego where he studied Neuroscience.